Page 1

Accolade Accolade Announces Results for Fiscal Second Quarter 2022 October 7 , 2021 • Fiscal second quarter 2022 revenue of $ 73.3 million , a 99 % increase compared to fiscal second quarter 2021 revenue of $ 36.8 million • Introduced Personalized Healthcare category , focused on human relationships and personalization using data to enable value - based care • Launched Accolade One and Accolade Care , two new healthcare solutions that combine Accolade's intelligent technology , advocacy services and team - based healthcare delivery SEATTLE , Oct. 07 , 2021 ( GLOBE NEWSWIRE ) -- Accolade , Inc. ( NASDAQ : ACCD ) today announced financial results for the fiscal second quarter ended August 31 , 2021 . " At Accolade , we believe it is time for a new approach that recognizes healthcare is a personal experience , and that we must stop rewarding a system that fundamentally doesn't work for patients or employers . At our recent Evolve21 customer conference , we were proud to introduce Personalized Healthcare , a new category that enables a nationally scalable model of value - based care . Personalized Healthcare requires all healthcare companies to step up and offer solutions that deliver a personalized experience , are powered by data - driven insights , and align the financial model with demonstrated value . Our new solutions - Accolade One and Accolade Care - deliver one of the broadest offering portfolios available to employers , " said Rajeev Singh , Accolade Chief Executive Officer . Accolade also announced today that it completed the acquisition of substantially all the assets of Health Reveal , a clinical artificial intelligence ( AI ) company focused on ensuring patients receive optimal , personalized chronic care to preempt adverse outcomes . Health Reveal's technology continually applies the latest medical guidelines to produce Reveals- personalized diagnostic and treatment recommendations . The addition of HealthReveal's technology and team will accelerate Accolade's focus on providing data - driven , clinically - based recommendations to our frontline care teams of physicians , specialists , nurses and health assistants . Financial Highlights for Fiscal Second Quarter ended August 31 , 2021 GAAP Financial Data : Revenue Net Loss Non - GAAP Financial Data ( 1 ) ; Adjusted EBITDA Adjusted Gross Profit Adjusted Gross Margin $ $ $ $ Three Months Ended August 31 , 2021 2020 ( in millions , except percentages ) 73.3 ( 62.4 ) ( 19.4 ) 30.0 40.9 % $ $ $ $ 36.8 ( 15.4 ) ( 8.7 ) 15.9 43.3 % % Change ( 2 ) 99 % ( 306 ) % ( 122 ) % 88 % ( 1 ) A reconciliation of GAAP to non - GAAP results has been provided in this press release in the accompanying Financial Tables . An explanation of these measures is also included below under the heading " Non - GAAP Financial Measures . " ( 2 ) Percentages are calculated from accompanying Financial Tables and may differ from percentage change of numbers in Financial Highlights table due to rounding . Financial Outlook Accolade provides forward - looking guidance on revenue and Adjusted EBITDA , a non - GAAP financial measure . For the fiscal third quarter ending November 30 , 2021 , we expect : • Revenue between $ 74.5 million and $ 76.5 million , which includes approximately $ 2.5 million of performance guarantee revenue that is expected to be recognized in the fiscal third quarter that was previously expected to be recognized in the fiscal fourth quarter Adjusted EBITDA between $ ( 21.5 ) million and $ ( 24.5 ) million